Trials / Completed
CompletedNCT01503606
Duration of Antibiotics Treatment With Cefazolin and Clarithromycin in Women With Preterm Premature Rupture of Membrane
Duration of Antibiotics Treatment With Cefazolin and Clarithromycin in Women With Preterm Premature Rupture of Membrane, Phase III Study.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 151 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the neonatal outcome and infant neurologic outcome whose mother were treated with cefazolin plus clarithromycin for one week or until delivery after preterm premature rupture of membrane.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cefazolin | Cefazolin 1.0gm IVs q 12 hours after randomization for one week |
| DRUG | Clarithromycin | clarithromycin 500mg po bid after randomization for one week |
| DRUG | Cefazolin | Cefazolin 1.0gm IVs q 12 hours after randomization until delivery |
| DRUG | Clarithromycin | clarithromycin 500mg po bid after randomization until delivery |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2020-12-01
- Completion
- 2021-12-01
- First posted
- 2012-01-04
- Last updated
- 2022-04-20
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01503606. Inclusion in this directory is not an endorsement.